Martin T. King MD, PhD

Dr. Martin King is an expert in prostate and gynecologic brachytherapy. He is interested in identifying therapeutic strategies that can improve the quality of life for men receiving radiation therapy for prostate cancer. He is the principal investigator of a multi-center randomized controlled trial, which evaluates whether a novel second-generation anti-androgen Darolutamide can be utilized in place of traditional androgen deprivation therapy for preserving erectile function while not sacrificing the potential for long-term disease control.